Get the Weekly Intelligence Brief — top committee picks every Sunday.
RDNT · NASDAQ · STOCK

RadNet, Inc.

Healthcare Updated August 11, 2026
$76.28
52W $50.82 – $85.84
52/100
$6.00B
-286.5
1.38
AI Committee Verdict
Watch
52/100
Conviction: Contested · 33% agreement · 6 analysts
Contested

Is RDNT Bullish or Bearish?

Mixed. Innellis AI committee rates RadNet, Inc. (RDNT) Watch with a composite score of 52/100 , based on 6 analysts with 33% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +7.78 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -12.22 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Value Analyst remains cautious — price-to-book of 5.1x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • Beta of 1.43 means this name should amplify a favorable market regime — Macro
Bear Case
  • Price-to-book of 5.1x prices in significant intangible value — Value
  • ROE of only -1.4% -- cheap may mean cheap for a reason — Value
  • RSI at 78 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
  • Bollinger bandwidth of 31.7% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
52/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 93%
of 192 Healthcare peers
Value Analyst bearish
30 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− Price-to-book of 5.1x prices in significant intangible value
Growth Analyst bullish
65 / 100 · Low confidence
Strong, accelerating growth with consistent execution
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 78 is in overbought territory
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 31.7% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
78.1
Overbought
MACD Histogram
1.309
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Support
$70.52
Resistance
$81.06
Bollinger %B
1.04
Above Upper Band
Price vs Moving Averages
EMA 9
$70.53 Above
EMA 21
$66.80 Above
EMA 50
$63.30 Above
EMA 200
$63.42 Above

Fundamental Analysis

Valuation
47
Profitability
0
Financial Health
41
Cash Flow
15
Valuation
P/E Ratio -286.5×
P/B Ratio 5.42×
PEG Ratio 4.77
Dividend Yield 0.00%
52W High $85.84
52W Low $50.82
Quality & Growth
ROE -171.1%
ROA -49.6%
Gross Margin 970.1%
Operating Margin 400.4%
Revenue Growth YoY
Debt / Equity 1.99
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -286.5 (inexpensive relative to a 15-40x range); Price-to-book of 5.4x; PEG ratio of 4.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -1.7%; Return on assets of -0.5%; Net margin of -0.9%; Gross margin of 9.7%; Current ratio of 1.48 (tight short-term liquidity); Debt-to-equity of 1.99; Free cash flow per share is negative (-0.75); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full RDNT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore RDNT Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime